Flavia Ejzykowicz
Impact in
-
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
- Inflammatory Biomarkers in Disease Prognosis
Papers in
-
- Renal cell carcinoma treatment 15
-
- Diabetes Treatment and Management 6
- Co-authors
- Thomas A. Burke (2 shared papers)Josephine Louella Feliciano (2 shared papers)Ralph P. Insinga (2 shared papers)David J. Vanness (1 shared paper)Swapnil N. Rajpathak (3 shared papers)Kristel Vandormael (1 shared paper)Sory Traore (1 shared paper)Alex Milinovich (1 shared paper)
- Journals
- Annals of Oncology (5 papers)Value in Health (5 papers)Journal of Medical Economics (2 papers)Clinical Therapeutics (2 papers)The Science of Diabetes Self-Management and Care (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Flavia Ejzykowicz
28 papers receiving 1.9k citations
Flavia Ejzykowicz's Hit Papers
Peers
Comparison fields: 5 of 63
- Pulmonary and Respiratory Medicine 1.2k
- Oncology 589
- Endocrinology, Diabetes and Metabolism 115
- Economics and Econometrics 142
- Cancer Research 36
Countries citing papers authored by Flavia Ejzykowicz
This map shows the geographic impact of Flavia Ejzykowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flavia Ejzykowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flavia Ejzykowicz more than expected).
Fields of papers citing papers by Flavia Ejzykowicz
This network shows the impact of papers produced by Flavia Ejzykowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flavia Ejzykowicz. The network helps show where Flavia Ejzykowicz may publish in the future.
Co-authors
The 25 scholars most cited alongside Flavia Ejzykowicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma Hit paper breakdown → | 2021 | 1355 |
| 2 | Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma Hit paper breakdown → | 2022 | 212 |
| 3 | 2016 | 77 | |
| 4 | 2022 | 72 | |
| 5 | 2019 | 64 | |
| 6 | 2019 | 53 | |
| 7 | 2024 | 37 | |
| 8 | 2019 | 21 | |
| 9 | 2017 | 14 | |
| 10 | 2015 | 13 | |
| 11 | 2013 | 7 | |
| 12 | 2018 | 7 | |
| 13 | 2018 | 5 | |
| 14 | 2023 | 5 | |
| 15 | 2024 | 5 | |
| 16 | 2020 | 4 | |
| 17 | 2024 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2022 | 2 | |
| 20 | 2015 | 1 |
About Flavia Ejzykowicz
Flavia Ejzykowicz is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Statistics and Probability, Oncology and Statistics, Probability and Uncertainty, having authored 31 papers that have together received 2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (15 papers), Diabetes Treatment and Management (6 papers), Statistical Methods in Clinical Trials (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cutaneous Melanoma Detection and Management (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Meta-analysis and systematic reviews (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Oncology (589 citations), Endocrinology, Diabetes and Metabolism (115 citations), Economics and Econometrics (142 citations) and Cancer Research (36 citations). Flavia Ejzykowicz has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Thomas A. Burke, Josephine Louella Feliciano, Ralph P. Insinga, David J. Vanness, Swapnil N. Rajpathak, Kristel Vandormael, Sory Traore, Alex Milinovich, Changhong Yu and Kevin M. Pantalone. Their work appears in journals such as Annals of Oncology, Value in Health, Journal of Medical Economics, Clinical Therapeutics and The Science of Diabetes Self-Management and Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.